Advertisement
Research Article Free access | 10.1172/JCI109553
Find articles by Arala-Chaves, M. in: JCI | PubMed | Google Scholar
Find articles by Higerd, T. in: JCI | PubMed | Google Scholar
Find articles by Porto, M. in: JCI | PubMed | Google Scholar
Find articles by Munoz, J. in: JCI | PubMed | Google Scholar
Find articles by Goust, J. in: JCI | PubMed | Google Scholar
Find articles by Fudenberg, H. in: JCI | PubMed | Google Scholar
Find articles by Loadholt, C. in: JCI | PubMed | Google Scholar
Published October 1, 1979 - More info
Products secreted by Streptococcus intermedius were studied for their effects on the immune response. Three different preparations of crude extracellular products from S. intermedius (CEP-Si) were found to have powerful suppressor activity in vitro as shown by inhibition of human lymphocyte proliferation (uptake of [3H]thymidine) and protein synthesis in response to a wide variety of stimulants, including mitogens and antigens, and suppression of plaque formation by human cells in response to sheep erythrocytes. CEP-Si was noncytotoxic, because cells incubated with high concentrations of CEP-Si and subsequently washed were viable and recovered their ability to respond to mitogens, and because leukocyte migration was not inhibited by CEP-Si, nor was the release of leukocyte migration inhibitory factor from sensitized lymphocytes. The possibility of antigen or mitogen competition was excluded. The effects of CEP-Si in vitro were time dependent and did not require the presence of monocytes. Cells pretreated with CEP-Si and then washed suppressed plaque formation by fresh autologous cells in highly stimulated cultures. CEP-Si injected into C57BL/6 mice also strongly suppressed their immune response to sheep erythrocytes, and the in vivo suppression was correlated with the effects of CEP-Si in vitro.